Company intelligence / Profile preview

Hefei RNAlfa Biotechnology

Hefei, Anhui, China

Ownership: Private
Development stage: Other

Overview

RNAlfa Biotechnology is a clinical-stage biotechnology company based in Hefei, China, specializing in the development of circular mRNA (cmRNA) therapeutics and vaccines. The company leverages its proprietary circular mRNA technology and lipid nanoparticle (LNP) delivery systems to create treatments with enhanced stability and prolonged protein expression compared to linear mRNA. Its lead program is a circular mRNA vaccine targeting COVID-19, which has entered clinical trials. Beyond infectious diseases, RNAlfa is expanding its pipeline into oncology and rare genetic disorders, aiming to provide next-generation RNA medicines with improved safety and efficacy profiles.

Therapeutic areas: OncologyRare DiseasesInfectious Diseases
Modalities: mRNA-based drugsVaccineLipid nanoparticle delivery therapy
Industry: Biotech

Partnerships

University of Science and Technology of China

Beyond the preview

Go deeper on Hefei RNAlfa Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei RNAlfa Biotechnology.

Explore the full profile